Dementia remains one of the most pressing public health challenges of our time. Its economic burden exceeds $1 trillion ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

But the 72-year-old Mendoza, who has not been diagnosed with Alzheimer’s, isn’t getting the exam at a doctor’s office or a clinical lab. She’s in a comfortable and familiar place, sipping Cuban coffee ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

A woman shares her story on living with Alzheimer's disease. A woman who lost 64 pounds on a compounded form of the weight ...

Preserving levels of brain glucose metabolism can both slow cognitive decline and reduces the risk of conversion to dementia.

Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk ...

The disease afflicts nearly seven million Americans, about one in every nine people over the age of 65, making it a leading ...

GlobalData epidemiologists forecast a rise in cases in the US from 2.97 million in 2024 to 4.06 million by 2033.

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

The Alzheimer’s Foundation of America is offering scholarships of up to $5,000 to college-bound high school seniors affected ...

The number of people living with neurological disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis and Parkinson’s disease, has increased as the population has aged. At the same time, ...